(Q45866492)

17 December 2017

title

Selection of men at high risk for disease recurrence for experimental adjuvant therapy following radical prostatectomy (English)

1 reference

17 December 2017

author name string

Partin AW

1

1 reference

17 December 2017

Piantadosi S

2

1 reference

17 December 2017

Sanda MG

3

1 reference

17 December 2017

Epstein JI

4

1 reference

17 December 2017

Marshall FF

5

1 reference

17 December 2017

Mohler JL

6

1 reference

17 December 2017

Brendler CB

7

1 reference

17 December 2017

Walsh PC

8

1 reference

17 December 2017

Simons JW

9

1 reference

17 December 2017

language of work or name

English

0 references

publication date

1 May 1995

1 reference

17 December 2017

published in

Urology

1 reference

17 December 2017

volume

45

1 reference

17 December 2017

page(s)

831-838

1 reference

17 December 2017

issue

5

1 reference

17 December 2017

cites work

Cancer statistics, 1993

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980091-0

7 January 2021

Systemic therapy of prostate cancer. New concepts from prostate cancer tumor biology

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980091-0

7 January 2021

Prostate-specific antigen as a measure of disease outcome in metastatic hormone-refractory prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980091-0

7 January 2021

Effect of radiation therapy on detectable serum prostate specific antigen levels following radical prostatectomy: early versus delayed treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980091-0

7 January 2021

Cancer Control following Anatomical Radical Prostatectomy: An Interim Report

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980091-0

7 January 2021

Long-term (15 years) results after radical prostatectomy for clinically localized (stage T2c or lower) prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980091-0

7 January 2021

Can radical prostatectomy alter the progression of poorly differentiated prostate cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980091-0

7 January 2021

5-year tumor recurrence rates after anatomical radical retropubic prostatectomy for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980091-0

7 January 2021

Cancer control and quality of life following anatomical radical retropubic prostatectomy: results at 10 years.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980091-0

7 January 2021

Prostatic Specific Antigen Related to Clinical Status 1 to 14 Years after Radical Retropubic Prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980091-0

7 January 2021

Is prostate specific antigen of clinical importance in evaluating outcome after radical prostatectomy.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980091-0

7 January 2021

The value of serum prostate specific antigen determinations before and after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980091-0

7 January 2021

Evaluation of serum prostate-specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980091-0

7 January 2021

The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980091-0

7 January 2021

Demonstration of a rational strategy for human prostate cancer gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980091-0

7 January 2021

Value of preoperative PSA in predicting pathologic stage of patients undergoing salvage prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980091-0

7 January 2021

10.1016/S0090-4295(99)80091-0

Identifiers

DOI

1 reference

17 December 2017

PubMed ID

7538245

1 reference

17 December 2017